Auctimet PG 2mg/500mg/15mg Tablet SR
Marketer
Bioaltus Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Auctimet PG 2mg/500mg/15mg Tablet SR
Glimepiride-metformin-pioglitazone 2mg/500mg/15mg extended-release tablets manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this combination medication improves blood sugar control by enhancing insulin effectiveness, thus reducing blood glucose. Follow your physician's prescribed dosage and regimen; take with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling doses. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic drugs, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals require medical consultation. Kidney function will be assessed before treatment commences. Limit alcohol consumption to reduce potential side effects.
Primary Ingredients of Auctimet PG 2mg/500mg/15mg Tablet SR
Not applicable. The provided text "undefined" lacks meaning and cannot be rephrased while maintaining original intent.
Uses of Auctimet PG 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Auctimet PG 2mg/500mg/15mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Auctimet PG 2mg/500mg/15mg Extended-Release tablets with food.
Common Side effects of Auctimet PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Auctimet PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Auctimet PG 2mg/500mg/15mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with a meal.
How Auctimet PG 2mg/500mg/15mg Tablet SR works:
Auctimet PG SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Auctimet PG 2mg/500mg/15mg Tablet SR and alcohol poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Auctimet PG 2mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Auctimet PG tablets (2mg/500mg/15mg) are likely not suitable for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Auctimet PG 2mg/500mg/15mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. In cases of severe kidney disease, Auctimet PG 2mg/500mg/15mg SR tablets are contraindicated. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Auctimet PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Auctimet PG 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Auctimet PG 2mg/500mg/15mg Tablet SR :
Should you forget to take a Auctimet PG 2mg/500mg/15mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Auctimet PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medication for diabetes |
3,018 People bought this recently